Legend Biotech Corp

Common Name
Legend Biotech
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
2,600
Ticker
LEGN
Exchange
NASDAQ/NGS
Description
Legend Biotech Corporation is a global biotechnology company primarily focused on the discovery and development of innovative cellular therapies. Its primary function centers around utilizing cutting-...
GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Legend Biotech's GHG Emissions Data Preview

In 2024, Legend Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Legend Biotech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Legend Biotech’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Legend Biotech’s data sources below and access millions more through our Disclosure Search.

a. Legend Biotech's ESG Report 2024
a. Legend Biotech's ESG Report 2024
b. Legend Biotech's ESG Report 2023
b. Legend Biotech's ESG Report 2023

Insights into Legend Biotech's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Legend Biotech amounted to 12,090 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Legend Biotech decreased by 8.39%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a b

Legend Biotech's Scope 1 Emissions Over Time

202320240200400600800tCO2e0%
  • Total Scope 1
  • Year-over-Year Change

What are Legend Biotech's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Legend Biotech were 769 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2023), Legend Biotech's Scope 1 emissions remained relatively stable, indicating that Legend Biotech's emissions have plateaued with no significant change in its operational footprint. a b

What are Legend Biotech's Scope 2 emissions?

In 2024, Legend Biotech reported Scope 2 greenhouse gas (GHG) emissions of 11,945 tCO₂e using the market-based method and 11,321 tCO₂e using the location-based method. a

Has Legend Biotech reduced its Scope 2 emissions over time?

Compared to the previous year (2023), Legend Biotech's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Legend Biotech 's emissions have plateaued with no significant change in its energy consumption footprint. a b

What methodology does Legend Biotech use for Scope 2 reporting?

In 2024, Legend Biotech reported its Scope 2 emissions using the market-based method and using the location-based method. a

Legend Biotech's Scope 2 Emissions Over Time

2023202403.5 k7 k10.5 k14 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Legend Biotech’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Legend Biotech reported Scope 1 greenhouse gas (GHG) emissions of 769 tCO₂e and total revenues of USD 627 millions. This translates into an emissions intensity of 1.23 tCO₂e per millions USD. a

Legend Biotech's Scope 1 Emissions Intensity Compared to Peers

202002,00020,000200,000Scope 1 Emissions (tCO2e)101005005,00050,000Revenues (Millions of USD)IncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MAzentaYear: 2023Scope 1: 14,399 tCO2eRevenue: $M 665Scope 1 Intensity: 21.65 tCO2e/$MVeracyteYear: 2023Scope 1: 448 tCO2eRevenue: $M 361Scope 1 Intensity: 1.24 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MGuardant HealthYear: 2023Scope 1: 1,659 tCO2eRevenue: $M 564Scope 1 Intensity: 2.94 tCO2e/$MModernaYear: 2023Scope 1: 11,240 tCO2eRevenue: $M 6,754Scope 1 Intensity: 1.66 tCO2e/$MWarby ParkerYear: 2023Scope 1: 961 tCO2eRevenue: $M 670Scope 1 Intensity: 1.43 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MMerit Medical SystemsYear: 2023Scope 1: 3,072 tCO2eRevenue: $M 1,257Scope 1 Intensity: 2.44 tCO2e/$MSotera HealthYear: 2023Scope 1: 39,206 tCO2eRevenue: $M 1,049Scope 1 Intensity: 37.36 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MVertex PharmaceuticalsYear: 2024Scope 1: 8,976 tCO2eRevenue: $M 11,020Scope 1 Intensity: 0.81 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$M

How does Legend Biotech's GHG emissions intensity compare to its peers?

In 2024, Legend Biotech reported a Scope 1 emissions intensity of 1.23 tCO₂e per millions USD. Compared to the peer group median of 2.44 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Legend Biotech rank on GHG emissions intensity within its industry?

In 2024, Legend Biotech ranked 3 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Legend Biotech among the top performers, with one of the lowest emissions intensities relative to peers. a

Want Full Access to Legend Biotech's GHG Emissions Dataset?
Sign Up

Explore Peer Companies

Ionis Pharmaceuticals Inc

Healthcare
Biotechnology
United States

BioMarin Pharmaceutical Inc

Healthcare
Biotechnology
United States

Alnylam Pharmaceuticals Inc

Healthcare
Biotechnology
United States

Cytokinetics Inc

Healthcare
Biotechnology
United States

Royalty Pharma PLC

Healthcare
Biotechnology
United States

Sarepta Therapeutics Inc

Healthcare
Biotechnology
United States